Trends in pharmacological sciences (Regular ed.), 2015-05, Vol.36 (5), p.297-309
2015
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Amyloid biomarkers in Alzheimer's disease
- Ist Teil von
- Trends in pharmacological sciences (Regular ed.), 2015-05, Vol.36 (5), p.297-309
- Ort / Verlag
- England: Elsevier Ltd
- Erscheinungsjahr
- 2015
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • Amyloid-β (Aβ) aggregation is central in Alzheimer disease the molecular pathogenesis. • The biomarkers amyloid PET and CSF Aβ42 are available to monitor Aβ pathology. • Amyloid PET and CSF Aβ42 show high concordance and similar diagnostic accuracy. • Standardization efforts are needed for both amyloid PET and CSF Aβ42.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0165-6147, 1873-3735eISSN: 1873-3735DOI: 10.1016/j.tips.2015.03.002Titel-ID: cdi_pubmed_primary_25840462
- Format
- –
- Schlagworte
- Advanced Basic Science, Alzheimer Disease - cerebrospinal fluid, Alzheimer Disease - diagnostic imaging, Alzheimer's disease, Amyloid beta-Peptides - cerebrospinal fluid, Amyloid beta-Peptides - standards, Animals, biomarker, Biomarkers - cerebrospinal fluid, cerebrospinal fluid, Clinical Medicine, Humans, Klinisk medicin, Medical and Health Sciences, Medicin och hälsovetenskap, Neurologi, Neurology, Neurosciences, Neurovetenskaper, Peptide Fragments - cerebrospinal fluid, Peptide Fragments - standards, positron emission tomography (PET), Positron-Emission Tomography - standards, Reference Standards, β-amyloid (Aβ)